Compare Natera Inc. Common Stock (NTRA) vs Targa Resources Inc. Common Stock (TRGP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Targa Resources Inc. Common Stock — how do they compare? Natera Inc. Common Stock trades at $394.16 (market cap $57.03B), while Targa Resources Inc. Common Stock trades at $290.9 (market cap $62.84B). The key difference: Natera Inc. Common Stock and Targa Resources Inc. Common Stock are close in size by market cap, and Targa Resources Inc. Common Stock pays a 1.71% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Targa Resources Inc. Common Stock for 5 Days on average.
| NTRA | TRGP | |
|---|---|---|
Market Cap | $57.03B | $62.84B |
Volume | 1,131,157 | 654,800 |
Sector | Health | Energy |
52-Week High | $425.64 | $302.25 |
52-Week Low | $179.42 | $146.30 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $56.18B | $82.28B |
Dividend Yield | — | 1.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
TRGP trades at $293.04, up 0.86% today, with a bullish technical signal driven by moving averages and a consensus analyst price target of $329.54. The company reported strong Q2 2026 EPS of $3.54, beating expectations, and maintains robust profitability with a net income margin of 13.54% and ROE of 72.27%. Recent news highlights a $1.25 quarterly dividend and sustainability reporting, reflecting stable operations.
The outlook is positive given earnings beats, high analyst buy ratings (82%), and projected revenue growth, though risks include commodity price exposure and high debt-to-asset ratio of 68.07%. The stock's current price near the analyst low target of $294.00 suggests potential upside if fundamentals hold.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Targa Resources Inc. Common Stock
Targa Resources provides midstream infrastructure for natural gas and natural gas liquids. Its services include gathering, processing, transportation, fractionation, storage, and export logistics.
Read more on TRGP →
